Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2026-03-10 @ 11:38 PM
Study NCT ID:
NCT04080804
Status:
RECRUITING
Last Update Posted:
2024-12-13
First Post:
2019-09-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
Sponsor:
Dan Zandberg
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Squamous Cell Carcinoma (HNSCC) | View |